Denying coronavirus patients access to hydroxychloroquine and azithromycin (z-pak) is unethical, French Prof. Didier Raoult said in an interview with Dr. Oz
Everyone is talking about the two anti-malaria drugs that became the game changer after a small clinical study led by renowned French research professor Didier Raoult found that Hydroxychloroquine is effective in the fight against coronavirus.
The study was led by renowned research professor Didier Raoult M.D/Ph.D, et. al in Marseille, France. The study showed that 100% of patients that received a combination of HCQ and Azithromycin tested negative and were virologically cured within 6 days of treatment. Prof. Raoult is a French biologist. He holds MD and Ph.D. degrees and specializes in infectious diseases. In 1984, he created the Rickettsia Unit at Aix-Marseille University (AMU). He also teaches infectious diseases in the Faculty of Medicine of Aix-Marseille University, and since 1982 has supervised many M.D. and Ph.D. degrees.
For the first time, Didier Raoult spoke with renowned U.S Dr. Oz in an interview. During the interview, Prof. Didier Raoult said it is unethical for doctors to deny coronavirus patiets access to hydroxychloroquine and azithromycin (z-pak) given the success of their study.
Dr. Oz speaks to infectious disease specialist Dr. Didier Raoult about the study of two FDA-approved drugs used in combination for treatment for COVID-19. Below is the video of their interview.